Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Want a daily digest of the top Nashville news?
Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.
Want a daily digest of the top Columbus news?
Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.
Want a daily digest of the top Dallas news?
Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.
Sign up for Axios NW Arkansas
Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters
Photo: John Beckmann/BSR Agency/Getty Images
The European Medicines Agency on Wednesday recommended Moderna's coronavirus vaccine for authorization in the European Union's 27 member states.
Why it matters: This is the second vaccine to be granted approval by the regulator. The European Commission — which has purchased 160 million doses of the Moderna vaccine — is likely to issue final approval this week.
- European Commission President Ursula von der Leyen tweeted that they "are working at full speed to approve it & make it available in the EU."
- The commission approved the Pfizer-BioNTech vaccine in December.
The big picture: The EU has been criticized for its slow rollout of the vaccine as cases continue to rise and countries enter a third wave of lockdowns.
- The EU officially began vaccinating with Pfizer-BioNTech shots on Dec. 27, but each country's distribution has been different.
- According to CNBC, Germany vaccinated about 240,000 people in the first week of EU approval, while France inoculated 516 people and the Netherlands had not even started vaccinating.
- The approval of the Moderna vaccine should further help the EU and its 446 million inhabitants resolve some supply issues.
What they're saying: "EMA’s human medicines committee (CHMP) has thoroughly assessed the data on the quality, safety and efficacy of the vaccine and recommended by consensus a formal conditional marketing authorisation be granted by the European Commission," EMA said in its statement.